This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Distinct pathways of ERK1/2 activation by hydroxy-carboxylic acid receptor-1
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsReceptor Mechanisms and Signaling · Computational Drug Discovery Methods · Neuropeptides and Animal Physiology
After this article [1] was published, concerns were raised regarding results presented in Figs 2–6.
Specifically:
The first author stated that errors were made during the preparation of Figs 2–6. The first author provided underlying blot and individual-level quantitative data for some of the panels in Figs 2–6. Upon editorial review, the underlying data provided were insufficient to resolve the above concerns, and raised further concerns for the validity and reliability of the published results in these figures.
In light of the above unresolved concerns, the PLOS One Editors retract this article.
GL did not respond to the final editorial decision. HQW, LHW, RPC, and JPL either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.